Patient and Health Care Professional Perspectives: A Case Study of the Lung Cancer Integrated Care Pathway

Bravi, Francesca; Ruscio, Eugenio Di; Frassoldati, Antonio; Cavallesco, Giorgio; Valpiani, Giorgia; Ferrozzi, Anna; Wienand, Ulrich; Carradori, Tiziano

doi:10.5334/ijic.3972

Cited by 7 publications

(6 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our findings show that coordination and monitoring of care had the lowest score, with pharmacists, psychologists, and nursing staff feeling disengaged and not involved in decision-making . This is similar to processes reported for patients with lung cancer (Bravi et al, 2018;Seys et al, 2017).…”

Section: Main Findingssupporting

confidence: 89%

“…All HCPs and managers were asked to complete the CPSET. This questionnaire has been widely used in international clinical practice and across various diseases as a care process/pathway audit tool (Bravi et al, 2018;Seys et al, 2017Seys et al, , 2013. It is a 29-item questionnaire to evaluate care processes in five areas: patient-focused organization, coordination of care, collaboration with primary care, communication with patients and family, and follow-up of care (Vanhaecht et al, 2007).…”

Section: Data Collectionmentioning

confidence: 99%

See 1 more Smart Citation

Evaluation of interprofessional care processes for patients treated with oral anticancer drugs

Kinnaer

Kenis

Foulon

et al. 2021

Journal of Interprofessional Care

View full text Add to dashboard Cite

Information on interprofessional team composition and functioning in the care for patients on oral anticancer drugs (OACDs), and how healthcare professionals (HCPs) evaluate in-hospital care processes is scarce. We aimed to investigate interprofessional care processes for OACD-patients in a partially mixedmethods study. A combination of (a) the CareProces Self-Evaluation Tool (CPSET), completed by HCP-team members by health profession who were either currently involved in care processes (oncologists and nurses) or potentially involved in future care (pharmacists, psychologists, social workers), and by hospital managers (N = 87) and (b) semi-structured interviews in a subsample of oncologists, nursing staff, and pharmacists (N = 26) were used. Care process coordination was evaluated poorly, mainly by nurses, pharmacists, and psychologists. Nurses and pharmacists believed that they were not engaged in the organization of OACD care, lacked role clarity, and perceived no meaningful interprofessional practice. HCPs had different perceptions toward timing and planning of patient education and follow-up. Monitoring of care processes occurred only occasionally and was unstructured resulting in apoor complication-management and variance within care processes. Care processes for OACD-patients showed opportunities for optimization of interprofessional practice in timing, planning, and monitoring. Rethinking care processes through co-design is needed.

show abstract

Section: Main Findingssupporting

confidence: 89%

Section: Data Collectionmentioning

confidence: 99%

Evaluation of interprofessional care processes for patients treated with oral anticancer drugs

Kinnaer

Kenis

Foulon

et al. 2021

Journal of Interprofessional Care

View full text Add to dashboard Cite

show abstract

“…It has shown to reduce waiting times for diagnosis and treatment [30,35,44,50,51]. This appears to be associated with better patient outcomes and higher patient satisfaction [34,36,[52][53][54]. The cost of cancer therapies is a significant issue, and it has been rising with the introduction of new (and often more expensive) therapies [13].…”

Section: Discussionmentioning

confidence: 99%

“…One of the aims of implementing an optimal lung cancer care pathway is to improve patients' experiences and satisfaction with their care [20]. Perspectives of lung cancer patients, evaluated using the OPTION (Opportunity for Treatment in Oncology) questionnaire, give the highest scores to 'respect', 'satisfaction', and 'trust' [53]. Offering written communication about diagnosis and maintaining patient privacy during consultations improves patient satisfaction [54].…”

Section: Studies On Patient Experiencementioning

confidence: 99%

Optimal Care Pathways for People with Lung Cancer- a Scoping Review of the Literature

Otty¹,

Brown²,

Sabesan³

et al. 2020

Int J Integr Care

View full text Add to dashboard Cite

Introduction: Much of the existing work around implementation of cancer optimal care pathways (OCP) has either focused exclusively on the clinical elements of care or has targeted individual stages in the cancer trajectory, rather than using a patient-centred or service delivery lens to inform the integration of care across the continuum. This review aimed to identify and summarise the available literature on lung cancer OCP. Methods: A scoping review was conducted, with literature across multiple databases and grey literature searched. Articles were included if the OCP was being used to manage adult patients with lung cancer and reported on either the development process and outcomes and/or barriers and facilitators associated with optimal care pathway development and/or uptake. Results: Of the 381 references screened, 32 articles were included. The lung cancer pathways reviewed varied significantly. A number of themes were identified including the development and implementation of the OCP; the use of quality indicators to audit the OCP; and studies on outcomes of the OCP incorporating timeliness of care delivery, patient experiences and health care utilisation and costs. Conclusions: The limited number of relevant articles found in this review may suggest that an OCP for lung cancer is still in its preliminary stages across the broader health systems.

show abstract

“…patients presenting only with a cough or are non-smokers) [8,9], poor communication of the diagnosis from the oncologist, [8,10] as well as the timeliness of diagnosis and receiving results [9]. Factors in uencing patient experience during cancer therapies include feeling uninvolved in treatment decisions [10], lack of information regarding treatment options [8,11,12] and inadequate management of side effects [8]. Patients also describe challenges in accessing supportive resources, including emotional support, indicating unmet supportive care needs for this population [8,13].…”

Section: Introductionmentioning

confidence: 99%

Diagnostic Timelines and Self-reported Symptoms of Patients With Lung and Gastrointestinal Cancers Undergoing Radiation Therapy

Yannitsos

Barbera

Al-Rashdan

et al. 2021

Preprint

View full text Add to dashboard Cite

Background: Previous studies have found that patients with lung cancer report worse patient experience compared to other tumour groups. Reasons that may negatively impact patient experience include delays in diagnosis as well as inadequate symptom management. The purpose of this study was to compare the diagnostic timelines and symptom reports of patients with lung and gastrointestinal (GI) cancers. Methods: This study included patients diagnosed with lung or GI cancers who attended a radiation oncology (RO) consultation and/or received radiation treatment between May and August 2019. Data collected included demographics, dates of diagnostic time points and self-reported symptom scores across 3 time points. A descriptive analysis was completed and the median number of days between time points were compared between tumour groups.Results: Patients with lung cancer experienced a greater diagnostic delay compared to GI patients, specifically regarding the median number of days between the first investigative test and biopsy, with a difference of 21 days between tumour groups (p<0.05). From RO consultation to the first treatment review appointment, 25% and 4% of lung and GI patients, respectively, reported worsening of symptoms. A greater proportion of lung patients reported worse symptoms scores during treatment compared to GI patients. This varied by specific symptom. Conclusions: Delays in receiving a diagnosis and worse symptom experience during radiation treatment were demonstrated in this study and may indicate potential targets to improve patient experience.

show abstract

Patient and Health Care Professional Perspectives: A Case Study of the Lung Cancer Integrated Care Pathway

Cited by 7 publications

References 28 publications

Evaluation of interprofessional care processes for patients treated with oral anticancer drugs

Evaluation of interprofessional care processes for patients treated with oral anticancer drugs

Optimal Care Pathways for People with Lung Cancer- a Scoping Review of the Literature

Diagnostic Timelines and Self-reported Symptoms of Patients With Lung and Gastrointestinal Cancers Undergoing Radiation Therapy

Contact Info

Product

Resources

About